Thank you for visiting our Investor Relations page. Your interest in our corporation is deeply appreciated.

Our goal is to develop effective cancer therapies that will speed up the eradication of metastatic tumors, without causing any harmful side effects. To achieve this, we have built effective targeted drug delivery systems that treat cancer by using a Graphene-oxide based nano-carrier to enhance controlled and targeted delivery of cytotoxic and anticancer medications.

As a plus, we are collaborating with a number of pharmaceutical firms with the aim of developing the effective diagnostic tests and medications for other cancer therapies, with the ultimate goal of completely eradicating the cancer menace.

Inquiries from individuals, biotech and pharmaceutical firms, financial analysts and investors are welcome.